Syntekabio Company
Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2009-09-15
Investor Type:
Undisclosed
Investment Stage:
N/A
Last Funding Date:
2019-12-17
Total Funding:
183902559.0
Technology:
AI based drug discovery and patient stratification, Self-developed bioinformatics tools for analyzing genomic data
Employee Number:
30-50
Number Of Exists:
1
Investors Number:
7.0
Industry:
Early Drug Development